Use of Hybrid Stage I to Stratify Between Single Ventricle Palliation and Biventricular Repair
World Journal for Pediatric and Congenital Heart Surgery · 2024
DOI: 10.1177/21501351241247501 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal for Pediatric and Congenital Heart Surgery, 2024. Verfasst von Justin Smith und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Rochester, Rochester, NY, USA. Hauptthemen laut MEDLINE: Palliative Care, Heart Ventricles, Heart Defects, Congenital. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Hybrid stage I palliation (HS1P) has been utilized for patients with single ventricle (SV) congenital heart disease (CHD). To date, reports on the use of HS1P for other indications including biventricular (BiV) CHD have been limited.
Methods
We performed a single-center retrospective cohort study of patients who underwent HS1P with an anticipated physiologic outcome of BiV repair, or with an undetermined SV versus BiV outcome. Patient characteristics and outcomes from birth through definitive repair or palliation were collected and reported with descriptive statistics.
Results
Nineteen patients underwent HS1P with anticipated BiV repair. Extracardiac and intracardiac risk factors (ICRF) were common. Ultimately, 13 (68%) patients underwent BiV repair, 1 (5%) underwent SV palliation, and 5 (26%) died prior to further palliation or repair. Resolution of ICRF tracked with BiV outcome (6/6, 100%), persistence of ICRF tracked with SV outcome or death (3/3, 100%). Twenty patients underwent HS1P with an undetermined outcome. Ultimately, 13 (65%) underwent BiV repair, 6 (30%) underwent SV palliation, and 1 (5%) underwent transplant. There were no deaths. Intracardiac risk factors were present in 15 of 20 patients (75%); BiV repair only occurred when all ICRF resolved (67%). Post-HS1P complications and reinterventions occurred frequently in both groups, through all phases of care.
Conclusions
Hybrid stage 1 palliation can be used to defer BiV repair and to delay decision between SV palliation and BiV repair. Resolution of ICRF was associated with ultimate outcome. In this high-risk group, complications are common, and mortality especially in the marginal BiV patient is high.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Rochester, Rochester, NY, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.
- Department of Cardiac Surgery and Pediatrics, Section of Pediatric Cardiovascular Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.
- Department of Pediatrics, Section of Pediatric Cardiovascular Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.
Zitieren
APA
Smith, J., Zampi, J. D., Balasubramanian, S., Mosher, B., Uzark, K., Lowery, R., Yu, S., & Romano, J. C. (2024). Use of Hybrid Stage I to Stratify Between Single Ventricle Palliation and Biventricular Repair. World Journal for Pediatric and Congenital Heart Surgery. https://doi.org/10.1177/21501351241247501
Vancouver
Smith J, Zampi JD, Balasubramanian S, Mosher B, Uzark K, Lowery R, et al. Use of Hybrid Stage I to Stratify Between Single Ventricle Palliation and Biventricular Repair. World Journal for Pediatric and Congenital Heart Surgery. 2024. doi:10.1177/21501351241247501
BibTeX
@article{Smith2024,
author = {Smith, Justin and Zampi, Jeffrey D and Balasubramanian, Sowmya and Mosher, Bryan and Uzark, Karen and Lowery, Ray and Yu, Sunkyung and Romano, Jennifer C},
title = {Use of Hybrid Stage I to Stratify Between Single Ventricle Palliation and Biventricular Repair},
journal = {World Journal for Pediatric and Congenital Heart Surgery},
year = {2024},
doi = {10.1177/21501351241247501}
}
EUVIMED